These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
411 related articles for article (PubMed ID: 28259949)
1. Berberine inhibits the proliferation of human nasopharyngeal carcinoma cells via an Epstein-Barr virus nuclear antigen 1-dependent mechanism. Wang C; Wang H; Zhang Y; Guo W; Long C; Wang J; Liu L; Sun X Oncol Rep; 2017 Apr; 37(4):2109-2120. PubMed ID: 28259949 [TBL] [Abstract][Full Text] [Related]
2. Baicalein inhibits growth of Epstein-Barr virus-positive nasopharyngeal carcinoma by repressing the activity of EBNA1 Q-promoter. Zhang Y; Wang H; Liu Y; Wang C; Wang J; Long C; Guo W; Sun X Biomed Pharmacother; 2018 Jun; 102():1003-1014. PubMed ID: 29710517 [TBL] [Abstract][Full Text] [Related]
3. Curcumin Inhibits Proliferation of Epstein-Barr Virus-Associated Human Nasopharyngeal Carcinoma Cells by Inhibiting EBV Nuclear Antigen 1 Expression. Liu L; Yang J; Ji W; Wang C Biomed Res Int; 2019; 2019():8592921. PubMed ID: 31687403 [TBL] [Abstract][Full Text] [Related]
4. Triptolide inhibits Epstein-Barr nuclear antigen 1 expression by increasing sensitivity of mitochondria apoptosis of nasopharyngeal carcinoma cells. Zhou H; Liu Y; Wang C; Liu L; Wang H; Zhang Y; Long C; Sun X J Exp Clin Cancer Res; 2018 Aug; 37(1):192. PubMed ID: 30111354 [TBL] [Abstract][Full Text] [Related]
6. Sequence Variation Analysis of Epstein-Barr Virus Nuclear Antigen 1 Gene in the Virus Associated Lymphomas of Northern China. Sun L; Zhao Z; Liu S; Liu X; Sun Z; Luo B PLoS One; 2015; 10(10):e0140529. PubMed ID: 26460969 [TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus nuclear antigen 1 (EBNA1) protein induction of epithelial-mesenchymal transition in nasopharyngeal carcinoma cells. Wang L; Tian WD; Xu X; Nie B; Lu J; Liu X; Zhang B; Dong Q; Sunwoo JB; Li G; Li XP Cancer; 2014 Feb; 120(3):363-72. PubMed ID: 24190575 [TBL] [Abstract][Full Text] [Related]
8. Activation of sterol regulatory element-binding protein 1 (SREBP1)-mediated lipogenesis by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) promotes cell proliferation and progression of nasopharyngeal carcinoma. Lo AK; Lung RW; Dawson CW; Young LS; Ko CW; Yeung WW; Kang W; To KF; Lo KW J Pathol; 2018 Oct; 246(2):180-190. PubMed ID: 29968360 [TBL] [Abstract][Full Text] [Related]
9. Detection of transcripts initiated from two viral promoters (Cp and Wp) in Epstein-Barr virus-infected nasopharyngeal carcinoma cells and biopsies. Chang Y; Sheen TS; Lu J; Huang YT; Chen JY; Yang CS; Tsai CH Lab Invest; 1998 Jun; 78(6):715-26. PubMed ID: 9645762 [TBL] [Abstract][Full Text] [Related]
10. Noninvasive diagnosis of nasopharyngeal carcinoma: nasopharyngeal brushings reveal high Epstein-Barr virus DNA load and carcinoma-specific viral BARF1 mRNA. Stevens SJ; Verkuijlen SA; Hariwiyanto B; Harijadi ; Paramita DK; Fachiroh J; Adham M; Tan IB; Haryana SM; Middeldorp JM Int J Cancer; 2006 Aug; 119(3):608-14. PubMed ID: 16572427 [TBL] [Abstract][Full Text] [Related]
11. [Effect of Epstein-Barr virus nuclear antigen 1 on cell proliferation and cell cycle in nasopharyngeal carcinoma cells]. Wan RQ; Li XP; Wang L; Lu J; Luo HN; Li G; Liu X; Zhang B Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Aug; 46(8):675-80. PubMed ID: 22169551 [TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus mRNA profiles and viral DNA methylation status in nasopharyngeal brushings from nasopharyngeal carcinoma patients reflect tumor origin. Ramayanti O; Juwana H; Verkuijlen SA; Adham M; Pegtel MD; Greijer AE; Middeldorp JM Int J Cancer; 2017 Jan; 140(1):149-162. PubMed ID: 27600027 [TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus-encoded EBNA1 inhibits the canonical NF-kappaB pathway in carcinoma cells by inhibiting IKK phosphorylation. Valentine R; Dawson CW; Hu C; Shah KM; Owen TJ; Date KL; Maia SP; Shao J; Arrand JR; Young LS; O'Neil JD Mol Cancer; 2010 Jan; 9():1. PubMed ID: 20051109 [TBL] [Abstract][Full Text] [Related]
14. Changes in the nasopharyngeal carcinoma nuclear proteome induced by the EBNA1 protein of Epstein-Barr virus reveal potential roles for EBNA1 in metastasis and oxidative stress responses. Cao JY; Mansouri S; Frappier L J Virol; 2012 Jan; 86(1):382-94. PubMed ID: 22013061 [TBL] [Abstract][Full Text] [Related]
15. Structure-based design of small-molecule inhibitors of EBNA1 DNA binding blocks Epstein-Barr virus latent infection and tumor growth. Messick TE; Smith GR; Soldan SS; McDonnell ME; Deakyne JS; Malecka KA; Tolvinski L; van den Heuvel APJ; Gu BW; Cassel JA; Tran DH; Wassermann BR; Zhang Y; Velvadapu V; Zartler ER; Busson P; Reitz AB; Lieberman PM Sci Transl Med; 2019 Mar; 11(482):. PubMed ID: 30842315 [TBL] [Abstract][Full Text] [Related]
16. Activation of lytic cycle of Epstein-Barr virus by suberoylanilide hydroxamic acid leads to apoptosis and tumor growth suppression of nasopharyngeal carcinoma. Hui KF; Ho DN; Tsang CM; Middeldorp JM; Tsao GS; Chiang AK Int J Cancer; 2012 Oct; 131(8):1930-40. PubMed ID: 22261816 [TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr nuclear antigen 1 contributes to nasopharyngeal carcinoma through disruption of PML nuclear bodies. Sivachandran N; Sarkari F; Frappier L PLoS Pathog; 2008 Oct; 4(10):e1000170. PubMed ID: 18833293 [TBL] [Abstract][Full Text] [Related]
18. Minicircle-oriP-miR-31 as a Novel EBNA1-Specific miRNA Therapy Approach for Nasopharyngeal Carcinoma. Wu J; Tan X; Lin J; Yuan L; Chen J; Qiu L; Huang W Hum Gene Ther; 2017 May; 28(5):415-427. PubMed ID: 28042945 [TBL] [Abstract][Full Text] [Related]
19. The sequence analysis of Epstein-Barr virus EBNA1 gene: could viral screening markers for nasopharyngeal carcinoma be identified? Banko AV; Lazarevic IB; Karalic DZ; Djukic VB; Cupic MD; Stevanovic G; Jovanovic TP Med Microbiol Immunol; 2019 Feb; 208(1):81-88. PubMed ID: 30203133 [TBL] [Abstract][Full Text] [Related]
20. Expression of VCA (viral capsid antigen) and EBNA1 (Epstein-Barr-virus-encoded nuclear antigen 1) genes of Epstein-Barr virus in Pichia pastoris and application of the products in a screening test for patients with nasopharyngeal carcinoma. Hu B; Hong G; Li Z; Xu J; Zhu Z; Li L Biotechnol Appl Biochem; 2007 May; 47(Pt 1):59-69. PubMed ID: 17129209 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]